Search Results - "Lori, Elisa"
-
1
Interleukin 21 (IL-21)/microRNA-29 (miR-29) axis is associated with natural resistance to HIV-1 infection
Published in AIDS (London) (13-11-2018)“…BACKGROUND:Interleukin-21 (IL-21) modulates HIV-1 infection through the elicitation of different antiviral mechanisms, including Th17 lineage commitment and…”
Get full text
Journal Article -
2
The Biological Foundations of Sarcopenia: Established and Promising Markers
Published in Frontiers in medicine (13-08-2019)“…Sarcopenia, the progressive loss of muscle mass and strength, is one of the major health issues in older adults, given its high prevalence accompanied by huge…”
Get full text
Journal Article -
3
446 Immunopeptidome changes mediated by a novel ERAP1 inhibitor leads to tumor growth inhibition
Published in Journal for immunotherapy of cancer (01-11-2020)“…BackgroundClinical data demonstrates increased antigen presentation diversity is a key factor in determining response rates to checkpoint inhibitors.1 In…”
Get full text
Journal Article -
4
Endoplasmic Reticulum Associated Aminopeptidase 2 (ERAP2) Is Released in the Secretome of Activated MDMs and Reduces in vitro HIV-1 Infection
Published in Frontiers in immunology (16-07-2019)“…Haplotype-specific alternative splicing of the endoplasmic reticulum (ER) aminopeptidase type 2 (ERAP2) gene results in either full-length (FL, haplotype A) or…”
Get full text
Journal Article -
5
Corrigendum: Endoplasmic Reticulum Associated Aminopeptidase 2 (ERAP2) Is Released in the Secretome of Activated MDMs and Reduces in vitro HIV-1 Infection
Published in Frontiers in immunology (06-12-2019)“…[This corrects the article DOI: 10.3389/fimmu.2019.01648.]…”
Get full text
Journal Article -
6
Abstract 1715: First in class inhibitors of ERAP1 have the potential to be a transformative immunotherapy in oncology
Published in Cancer research (Chicago, Ill.) (01-07-2021)“…Abstract Clinical data demonstrates increased antigen presentation diversity is an important factor in determining response rates to checkpoint inhibitors. In…”
Get full text
Journal Article -
7
Abstract 5551: Potent oral ERAP1 inhibitors modify the immunopeptidome in vivo and are novel immunotherapy agents
Published in Cancer research (Chicago, Ill.) (15-08-2020)“…Abstract Immune checkpoint therapy has changed the cancer treatment paradigm, however the majority of patients respond poorly to T cell checkpoint blockade…”
Get full text
Journal Article -
8
Supporting staff in their practice of restitution at Victoria West Elementary School
Published 01-01-2003“…Student discipline and classroom management are common areas of concern for teachers within the British Columbia school system. As governments and school…”
Get full text
Dissertation